Pharma Mar SA ( (ES:PHM) ) has provided an update.
Pharma Mar S.A. has announced the convening of its Ordinary General Shareholders’ Meeting, scheduled for June 18, 2025, at the Villa de Colmenar Viejo Municipal Auditorium in Madrid. The meeting will address several key agenda items, including the approval of annual accounts, management reports, and a proposal for dividend distribution. Additionally, the re-election of a director and the approval of a new share delivery plan for employees are on the agenda, indicating the company’s focus on strategic governance and employee engagement.
More about Pharma Mar SA
Pharma Mar S.A. is a biopharmaceutical company based in Spain, primarily focused on the development and commercialization of marine-derived drugs for cancer treatment. The company is a leader in the biotechnology industry, with a strong emphasis on innovative oncology solutions.
YTD Price Performance: 5.62%
Average Trading Volume: 799
Technical Sentiment Signal: Sell
Current Market Cap: $1.53B
For an in-depth examination of PHM stock, go to TipRanks’ Stock Analysis page.